Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor

MLA

Robert Rejdak, et al. Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor. Jan. 2021. EBSCOhost, https://doi.org/10.5167/uzh-209866.

APA

Robert Rejdak, Yacoub A. Yousef, Mutasem Elfalah, Mo’ath AlShawabkeh, Sandrine Zweifel, Jehad Meqbil, Saif Aldeen AlRyalat, Amal Alwreikat, Muawyah D Al Bdour, Mario Damiano Toro, Maysa Al-Hussaini, Mohammed Abu-Ameerh, Osama H. Ababneh, Rashed Mustafa Nazzal, Almutez M. Gharaibeh, & Zuhair Sharif. (2021). Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor. https://doi.org/10.5167/uzh-209866

Chicago

Robert Rejdak, Yacoub A. Yousef, Mutasem Elfalah, Mo’ath AlShawabkeh, Sandrine Zweifel, Jehad Meqbil, Saif Aldeen AlRyalat, et al. 2021. “Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor,” January. doi:10.5167/uzh-209866.